The ACA Marketplace 2027 open enrollment period starts November 1, 2026, in most states. It is the second season since the enhanced premium tax credits expired, the first with a full year of enrollment data showing exactly how consumers responded to the shock. The picture is not reassuring for anyone betting on a quick recovery in exchange volume. But investors who frame this purely as a demand story are missing the more important question: which insurers priced correctly for the world that actually arrived?
The Bull Case: Pain Now, Cleaner Pool Later
The enhanced subsidies helped fuel a surge in ACA enrollment that topped out during the 2025 plan year at around 24 million people, after having been closer to roughly 11 to 12 million in the years just before the pandemic. That surge enrolled millions of marginal, relatively healthy members whose premiums cross-subsidized sicker ones. They left first when the credits disappeared.
Losses were not evenly distributed by age. Adults between 18 and 34 accounted for a disproportionate share of the drop, which is the pattern insurers had predicted and the one that drives everything downstream. A risk pool loses its healthiest members first when the net price rises, because those are the members for whom the coverage was closest to optional. That is brutal in the short run. In the long run, it concentrates members whose spending is predictable, and predictability is something actuaries can price for.
Centene is the clearest case study. Centene has pointed to Marketplace pricing and risk transfer dynamics as part of how results have tracked against its expectations, a signal that its underwriters read the adverse selection coming and raised premiums accordingly. Insurers that proposed a median premium increase of 15% for 2027 added, on average, about four percentage points to account for the lasting effects of the subsidy expiration and a sicker risk pool. Carriers that baked that assumption into their rates can earn their way through the transition. Elevance reinforced the point: in its third-quarter 2026 update, it raised full-year adjusted EPS guidance to at least $29.00 and said it had improved its 2026 earnings baseline for 2027 growth expectations.
The Bear Case: The Pool Keeps Selecting Against You
The CBO estimated ACA Marketplace enrollment would fall from a peak of 22.4 million in 2025 to 13.1 million in 2027. That is not a temporary dip. A market half its former size means permanently reduced premium revenue, permanently narrower margins on fixed administrative costs, and a recurring adverse selection problem. The read is that the pool keeps selecting against the plan year over year, because the people choosing to pay a January premium in a world without enhanced subsidies are increasingly the sickest slice of an already-shrunken pool.
Molina is the counterexample to Centene’s relative success. In the second quarter, Molina’s Marketplace business posted a medical care ratio of 88.9%, up 3.5 percentage points year over year, with the increase reflecting prior year risk adjustment and program integrity initiatives and an unfavorable member acuity mix. Management’s response was retreat: Molina has said it plans to focus its marketplace membership in roughly six states rather than the 13 or 14 it has operated in. Oscar faces its own reckoning: a recent Zacks note said consensus estimates for Oscar’s 2026 and 2027 revenues and earnings indicate year-over-year decreases.
More than nine insurers have announced ahead of the 2027 plan year that they will stop offering ACA marketplace plans nationally or in specific states, citing the post-subsidy environment among the pressures reshaping the market. Fewer competitors sounds like a pricing gift, but exits also mean thinner markets, concentrated risk, and state regulators who may cap rate increases exactly when carriers need flexibility most.
Where the Evidence Leads
The debate comes down to whether this is a pricing cycle or a structural unwind. The evidence leans toward the former, but only for carriers that acted decisively. Nationally, filings show a median proposed premium increase of about 15% for 2027. Those are not the rates of an industry in denial. They are the rates of an industry trying to price its way to solvency. The question for this enrollment season is how many consumers absorb those increases versus walk away, shrinking the pool further.
Centene and Elevance, both of which entered 2027 with disciplined footprint decisions and actuarially defended pricing, are better positioned to benefit from the eventual stabilization. Oscar’s heavy ACA concentration and contracting revenue estimates make it the highest-risk name in the group. Molina’s partial exit is honest about its Q2 results but leaves its remaining book exposed in fewer, potentially less competitive markets.
What Could Change the Debate
Watch the first weekly enrollment snapshots starting this week. If sign-ups track meaningfully above the CBO’s 13.1 million ceiling, the sicker-pool thesis weakens and the premium revenue base for exchange-heavy names stabilizes faster than feared. A congressional move to restore any version of enhanced credits would price every exchange insurer upward overnight, though various narrower proposals have circulated in both chambers but none has passed both chambers and been enacted. Absent that, the argument that a leaner, accurately priced exchange market favors disciplined incumbents over growth-at-any-cost ones is the stronger one right now.
